Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
CT-868 is an injectable GLP-1/GIP dual agonist in development as an adjunct therapy to insulin for T1D
Many have reported reductions in their calorie consumption since they started on the meds
It serves as a cofactor for lysyl oxidase, a key enzyme in collagen and elastin cross-linking, and for mitochondrial cytochrome c oxidase, thereby supporting cellular energy metabolism
However, for older adults, loss of muscle mass is a major functional concern
US$ 22.22
US$ 27.93
US$ 24.32
